Itau Unibanco Holding S.A.’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-870	Closed	-$27K	–	996
2019 Q3	$27K	Hold	870	–	–	﹤0.01%	259
2019 Q2	$27K	Buy	870 +133	+18%	+$2.8K	﹤0.01%	568
2019 Q1	$14K	Hold	737	–	–	﹤0.01%	569
2018 Q4	$14K	Buy	737 +80	+12%	+$3K	﹤0.01%	569
2018 Q3	$34K	Buy	657 +177	+37%	+$9.65K	﹤0.01%	560
2018 Q2	$21K	Buy	480 +296	+161%	+$12.7K	﹤0.01%	670
2018 Q1	$7K	Buy	+184	New	+$4.91K	﹤0.01%	562

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Itau Unibanco Holding S.A.'s GTHX Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2019, closing a stake of 870 shares — an estimated $27K sold.

Itau Unibanco Holding S.A. first reported a position in GTHX in Q1 2018 and held it in 7 quarters. The position peaked at $34K in Q3 2018. 98 funds tracked by Wall St. Rank hold GTHX as of Q4 2019.

Itau Unibanco Holding S.A. reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 870 G1 Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $27K.
Itau Unibanco Holding S.A. first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Itau Unibanco Holding S.A.'s G1 Therapeutics, Inc. Common Stock position peaked at $34K in Q3 2018.
98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.